Mutlu Doğan
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 41
- Colorectal Cancer Treatments and Studies 10
- Inflammatory Biomarkers in Disease Prognosis 10
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 4
-
- Lung Cancer Treatments and Mutations 4
- Renal cell carcinoma treatment 3
- Co-authors
- Nurullah Zengin (19 shared papers)Doğan Uncu (14 shared papers)Esra Karakaş (3 shared papers)Ahmet Demirkazık (9 shared papers)Öznur Bal (13 shared papers)Nuriye Özdemir (6 shared papers)Nebi Serkan Demirci (4 shared papers)Hakan Akbulut (9 shared papers)
- Journals
- Medical Oncology (4 papers)Journal of Clinical Oncology (3 papers)Leukemia Research (2 papers)Supportive Care in Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesCambodia
In The Last Decade
Mutlu Doğan
74 papers receiving 564 citations
Peers
Comparison fields: 5 of 75
- Oncology 226
- Internal Medicine 27
- Psychiatry and Mental health 61
- Cancer Research 49
- Otorhinolaryngology 11
Countries citing papers authored by Mutlu Doğan
This map shows the geographic impact of Mutlu Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlu Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlu Doğan more than expected).
Fields of papers citing papers by Mutlu Doğan
This network shows the impact of papers produced by Mutlu Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlu Doğan. The network helps show where Mutlu Doğan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mutlu Doğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 63 | |
| 2 | 2015 | 45 | |
| 3 | 2015 | 30 | |
| 4 | 2016 | 29 | |
| 5 | Endpoints in oncology clinical trials. | 2018 | 29 |
| 6 | 2017 | 24 | |
| 7 | 2016 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2015 | 18 | |
| 10 | 2018 | 17 | |
| 11 | 2017 | 16 | |
| 12 | 2005 | 13 | |
| 13 | 2020 | 12 | |
| 14 | 2006 | 11 | |
| 15 | Recurrent rhinolithiasis: a case report with review of the literature. | 2012 | 10 |
| 16 | 2021 | 9 | |
| 17 | 2017 | 9 | |
| 18 | 2011 | 9 | |
| 19 | 2010 | 8 | |
| 20 | 2012 | 8 |
About Mutlu Doğan
Mutlu Doğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Molecular Biology and Surgery, having authored 83 papers that have together received 571 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Oncology (226 citations), Internal Medicine (27 citations), Psychiatry and Mental health (61 citations), Cancer Research (49 citations) and Otorhinolaryngology (11 citations). Mutlu Doğan has collaborated with scholars based in Türkiye, United States and Cambodia. Frequent co-authors include Nurullah Zengin, Doğan Uncu, Esra Karakaş, Ahmet Demirkazık, Öznur Bal, Nuriye Özdemir, Nebi Serkan Demirci, Hakan Akbulut, Fikri İçlı and Umut Demırcı. Their work appears in journals such as Medical Oncology, Journal of Clinical Oncology, Leukemia Research, Supportive Care in Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.